Enliven Therapeutics stockELVN
Enliven Therapeutics trades at $44.79, 28.1% below its 52-week high (Aug 5, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +190.8% year to date, +142.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.
Ratings, candles, signals and the screener for ELVN — after you log in
Open the terminalFrequently asked questions about Enliven Therapeutics
What is the Enliven Therapeutics stock price?
At the close on Nov 5, 2026: $44.79 (−5.21% on the day). 52-week high: $62.32 on Aug 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Enliven Therapeutics report earnings?
The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed 0% year over year, revenue 0%.
Does Enliven Therapeutics pay dividends?
No, Enliven Therapeutics does not pay dividends.
Where does Enliven Therapeutics trade and how to buy it?
Ticker ELVN, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Enliven Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ELVN are in the terminal after you log in.